- Investing Ideas
- /
- Food, Beverage & Tobacco Healthcare Sector
Food, Beverage & Tobacco Healthcare Sector
Results
2264
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2264 companies
Cochlear
Market Cap: AU$19.7b
Provides implantable hearing solutions for children and adults worldwide.
COH
AU$301.66
7D
-3.7%
1Y
-0.7%
Solventum
Market Cap: US$12.5b
A healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally.
SOLV
US$72.85
7D
-2.1%
1Y
22.1%
Baxter International
Market Cap: US$12.5b
Through its subsidiaries, provides a portfolio of healthcare products in the United States.
BAX
US$24.27
7D
0.7%
1Y
-32.9%
Viatris
Market Cap: US$12.5b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$10.65
7D
2.3%
1Y
-9.1%
Encompass Health
Market Cap: US$12.3b
Provides post-acute healthcare services in the United States and Puerto Rico.
EHC
US$123.54
7D
3.7%
1Y
38.2%
Doximity
Market Cap: US$11.9b
Operates as a digital platform for medical professionals in the United States.
DOCS
US$64.36
7D
0.5%
1Y
76.7%
Ascendis Pharma
Market Cap: US$11.8b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.
ASND
US$192.80
7D
0.9%
1Y
40.7%
Universal Health Services
Market Cap: US$11.6b
Through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities.
UHS
US$184.70
7D
3.5%
1Y
-18.9%
BioMarin Pharmaceutical
Market Cap: US$11.0b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$57.96
7D
-0.6%
1Y
-37.4%
Moderna
Market Cap: US$10.9b
A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.
MRNA
US$26.89
7D
0%
1Y
-69.0%
Qiagen
Market Cap: US$10.7b
Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.
QGEN
US$49.20
7D
-0.06%
1Y
1.6%
Revvity
Market Cap: US$10.6b
Provides health sciences solutions, technologies, and services worldwide.
RVTY
US$91.70
7D
0.8%
1Y
-24.0%
Align Technology
Market Cap: US$10.4b
Designs, manufactures, and markets Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally.
ALGN
US$143.58
7D
0.5%
1Y
-37.2%
Caris Life Sciences
Market Cap: US$10.4b
An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
CAI
US$35.07
7D
2.3%
1Y
n/a
Exelixis
Market Cap: US$10.2b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$37.86
7D
-1.6%
1Y
46.9%
Penumbra
Market Cap: US$9.9b
Designs, develops, manufactures, and markets medical devices in the United States and internationally.
PEN
US$255.72
7D
-0.6%
1Y
31.0%
DaVita
Market Cap: US$9.8b
Provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.
DVA
US$137.42
7D
2.0%
1Y
-8.8%
Ensign Group
Market Cap: US$9.6b
Provides skilled nursing, senior living, and rehabilitative services.
ENSG
US$169.01
7D
1.6%
1Y
16.8%
Hims & Hers Health
Market Cap: US$9.5b
Operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally.
HIMS
US$43.38
7D
-10.2%
1Y
161.8%
Molina Healthcare
Market Cap: US$9.4b
Provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces.
MOH
US$173.60
7D
7.7%
1Y
-50.0%
BridgeBio Pharma
Market Cap: US$9.3b
A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.
BBIO
US$48.88
7D
-4.5%
1Y
96.4%
Sonic Healthcare
Market Cap: AU$14.2b
Offers medical diagnostic and administrative services to medical practitioners, hospitals, community health services, and patients in Australia, the United States, Germany, and internationally.
SHL
AU$28.74
7D
2.8%
1Y
3.7%
Verona Pharma
Market Cap: US$9.1b
A biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs.
VRNA
US$105.80
7D
0.6%
1Y
278.0%
Avantor
Market Cap: US$8.8b
Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
AVTR
US$12.88
7D
-1.5%
1Y
-49.4%
Elanco Animal Health
Market Cap: US$8.7b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$17.46
7D
-2.0%
1Y
17.5%
Exact Sciences
Market Cap: US$8.6b
Provides cancer screening and diagnostic test products in the United States and internationally.
EXAS
US$47.00
7D
4.7%
1Y
-21.2%
Bio-Techne
Market Cap: US$8.6b
Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.
TECH
US$54.33
7D
-0.7%
1Y
-25.2%
Madrigal Pharmaceuticals
Market Cap: US$8.5b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$391.66
7D
4.9%
1Y
52.9%
Henry Schein
Market Cap: US$8.3b
Provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide.
HSIC
US$68.64
7D
-0.5%
1Y
-1.8%
Globus Medical
Market Cap: US$8.3b
A medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
GMED
US$60.73
7D
-3.3%
1Y
-12.7%
Halozyme Therapeutics
Market Cap: US$8.2b
A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.
HALO
US$71.13
7D
9.2%
1Y
14.4%
Roivant Sciences
Market Cap: US$8.0b
A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.
ROIV
US$11.72
7D
-2.0%
1Y
-0.6%
Masimo
Market Cap: US$8.0b
Develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide.
MASI
US$145.65
7D
-6.6%
1Y
18.1%
Charles River Laboratories International
Market Cap: US$7.8b
Charles River Laboratories International, Inc.
CRL
US$159.58
7D
3.0%
1Y
-21.9%
HealthEquity
Market Cap: US$7.8b
Provides technology-enabled services platforms to consumers and employers in the United States.
HQY
US$89.04
7D
-0.3%
1Y
18.8%
Bio-Rad Laboratories
Market Cap: US$7.6b
Manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.
BIO
US$288.16
7D
0.3%
1Y
-8.9%